HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Georg Varga Selected Research

Georg Varga Research Topics

Disease

12Inflammation (Inflammations)
01/2021 - 07/2003
5Crohn Disease (Crohn's Disease)
01/2021 - 03/2015
5Infections
01/2018 - 10/2007
3Arthritis (Polyarthritis)
01/2021 - 01/2016
3Ulcerative Colitis
01/2021 - 07/2020
2Neoplasms (Cancer)
01/2022 - 03/2015
2Hypersensitivity (Allergy)
08/2014 - 01/2002
2Atherosclerosis
07/2013 - 01/2013
2Lymphopenia (Lymphocytopenia)
07/2013 - 01/2013
2Skin Diseases (Skin Disease)
01/2006 - 12/2003
1Psoriatic Arthritis
01/2022
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2020
1Lung Neoplasms (Lung Cancer)
01/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018
1Psoriasis (Pustulosis Palmaris et Plantaris)
11/2016
1Juvenile Arthritis (Juvenile Idiopathic Arthritis)
01/2016
1Necrosis
01/2016
1Simian Acquired Immunodeficiency Syndrome
11/2015
1Colitis
07/2015
1Autoimmune Diseases (Autoimmune Disease)
08/2014
1Endotoxemia
06/2013
1Sepsis (Septicemia)
06/2013
1Primary Immunodeficiency Diseases
01/2012
1Leishmaniasis
09/2008
1Acquired Immunodeficiency Syndrome (AIDS)
01/2005
1Contact Dermatitis (Eczema, Contact)
07/2004
1Lethargy
11/2003
1Glomerulonephritis
07/2003
1Allergic Contact Dermatitis
01/2002
1Irritant Dermatitis
01/2002

Drug/Important Bio-Agent (IBA)

6CytokinesIBA
01/2022 - 04/2010
3Janus KinasesIBA
01/2021 - 07/2020
3tofacitinibIBA
01/2021 - 07/2020
3AlarminsIBA
01/2020 - 06/2013
3Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2016 - 03/2015
3IntegrinsIBA
01/2012 - 01/2002
2LigandsIBA
06/2013 - 09/2008
1Peptides (Polypeptides)IBA
01/2022
1Rituximab (Mabthera)FDA Link
01/2022
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021
1MyokinesIBA
01/2021
1Interleukin-17 (Interleukin 17)IBA
01/2021
1MyostatinIBA
01/2021
1Janus Kinase InhibitorsIBA
07/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2018
1Doxycycline (Periostat)FDA LinkGeneric
11/2016
1Cathepsin BIBA
01/2016
1Pathogen-Associated Molecular Pattern MoleculesIBA
11/2015
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2015
1Therapeutic UsesIBA
07/2015
1Dextran SulfateIBA
07/2015
1Biomarkers (Surrogate Marker)IBA
03/2015
1Phosphotransferases (Kinase)IBA
10/2014
1GlucocorticoidsIBA
08/2014
1ChemokinesIBA
04/2014
1InterferonsIBA
07/2013
1oxidized low density lipoproteinIBA
07/2013
1Interleukin-2 (IL2)IBA
07/2013
1Sphingosine-1-Phosphate ReceptorsIBA
07/2013
1Fingolimod Hydrochloride (FTY720)FDA Link
07/2013
1KRP-203IBA
07/2013
1S100A12 ProteinIBA
06/2013
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2013
1LDL Receptors (LDL Receptor)IBA
01/2013
1LyasesIBA
01/2013
1LipopolysaccharidesIBA
10/2009
1polyacrylamideIBA
10/2009
1Lymphotoxin-alpha (Lymphotoxin)IBA
09/2008
1Calcitriol Receptors (Calcitriol Receptor)IBA
10/2007
1pimecrolimus (Elidel)FDA Link
01/2006
1Calcineurin InhibitorsIBA
01/2006
1SteroidsIBA
01/2006
1VaccinesIBA
01/2005
1DermaVirIBA
01/2005
1Interleukin-15 (Interleukin 15)IBA
07/2004
1Antiviral Agents (Antivirals)IBA
07/2004
1Keratin-14 (Keratin 14)IBA
07/2004
1BiglycanIBA
07/2003
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2003
1Messenger RNA (mRNA)IBA
07/2003
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
07/2003
1CD18 AntigensIBA
01/2002

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2018
1Therapeutics
08/2014
1Subcutaneous Injections
10/2009
1Intravenous Injections
11/2003